Evidence map›Paper›PMID 41315121›Full record

ArticleAIDS and behavior2026

Poor Oral HIV Pre-Exposure Prophylaxis (PrEP) Persistence in an Integrated PrEP/STI Program in Malawi.

Grace E Mulholland, Mitch Matoga, Jane S Chen, Esther Mathiya, Griffin J Bell, Beatrice Ndalama, Tapiwa Munthali, Naomi Nyirenda, Naomi Bonongwe, Claire Pedersen and 5 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Grace E MulhollandDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. gem@unc.edu.ORCID http://orcid.org/0000-0003-0046-2144
Mitch MatogaUNC Project-Malawi, Lilongwe, Malawi.
Jane S ChenDivision of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Esther MathiyaUNC Project-Malawi, Lilongwe, Malawi.
Griffin J BellDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Beatrice NdalamaUNC Project-Malawi, Lilongwe, Malawi.
Tapiwa MunthaliUNC Project-Malawi, Lilongwe, Malawi.
Naomi NyirendaUNC Project-Malawi, Lilongwe, Malawi.
Naomi BonongweUNC Project-Malawi, Lilongwe, Malawi.
Claire PedersenUNC Project-Malawi, Lilongwe, Malawi.
Edward JereUNC Project-Malawi, Lilongwe, Malawi.
Mina C HosseinipourDivision of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Zakaliah MphandeLighthouse Trust, Lilongwe, Malawi.
Irving F HoffmanDivision of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Sarah E RutsteinDivision of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Training in Sexually Transmitted Infections and HIVT32AI007001 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SENA-SOBERANO, ARLENE C. · 1985 to 2025
$10.9M
Center for AIDS Research, University of North Carolina at Chapel Hill P30-AI050410Differentiated Service Delivery (DSD) Programme of IAS - the International AIDS Society Differentiated Service Delivery (DSD) Programme of IAS - the International AIDS SocietyDoris Duke Charitable Foundation 2020143National Institute of Allergy and Infectious Diseases T32-AI007001NIAID NIH HHS P30 AI050410NIAID NIH HHS T32 AI007001University of North Carolina at Chapel Hill Department of Medicine Physician Science Training Program University of North Carolina at Chapel Hill Department of Medicine Physician Science Training Program
6 · The paper itself

Abstract

The integration of HIV pre-exposure prophylaxis (PrEP) into STI services can improve PrEP uptake among a population at elevated risk of acquiring HIV. The effectiveness of PrEP relies on ongoing coverage during periods of HIV risk, however, and little is known about longitudinal PrEP use among people accessing PrEP through STI clinics in sub-Saharan Africa. In this study, we analyzed routine records data from people who newly initiated PrEP at an STI clinic in Lilongwe, Malawi in March-December 2022. We assessed PrEP persistence among clients who received Malawi's standard-of-care PrEP services (n = 662) and reweighted the data to reflect the baseline distribution of age, sex, and PrEP indication among the full study population (n = 835). We used weighted generalized estimating equations to estimate the proportion of clients expected to persist on PrEP if all clients had received Malawi's standard-of-care services. We also assessed predictors of persistence and described re-engagement in PrEP among clients who did not persist. We estimated that, had all clients received standard-of-care services, 17% (95% CI: 14%, 20%), 7% (95% CI: 6%, 10%), and 4% (95% CI: 3%, 5%) would have persisted on PrEP at 1, 3, and 6 months, respectively, and that 8% (95% CI: 5%, 11%) of those who did not persist on PrEP at 1 month would have re-engaged in PrEP services by 12 months. Persistence varied by age and PrEP indication. Our findings indicate very low PrEP persistence in this population and suggest opportunities to support ongoing PrEP use in settings with integrated PrEP/STI services.

Indexed as

Anti-HIV AgentsHIV InfectionsMedication AdherencePre-Exposure ProphylaxisAdministration, OralAdolescentAdultFemaleHumansMalawiMaleMiddle AgedYoung AdultAnti-HIV AgentsAfricaCohort studiesHIV preventionLMICPrEPSexually transmitted infections/diseases

Identifiers

PMID41315121
PMCPMC13167809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.